The immune microenvironments of lung and intraocular tumors

Bulletin du Cancer

Volumn 98, Issue 6, 2011, Pages

  Sautès Fridman, Catherine ^a,b,c   Dieu Nosjean, Marie Caroline ^a,b,c   Damotte, Diane ^a,b,c,d   Fisson, Sylvain ^a,b,c   Fridman, Wolf Herman ^a,b,c,e  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔTEL DIEU   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Adaptive immunity; Eye; Immune response; Lung cancer; Lymphoma; Tertiary lymphoid structure; Tumor microenvironment

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; DENDRITIC CELL LYSOSOME ASSOCIATED MEMBRANE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INTRAOCULAR TUMOR; LUNG ALVEOLUS EPITHELIUM; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; LYMPHOID ORGAN; NONHODGKIN LYMPHOMA; NONHUMAN; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIMARY INTRAOCULAR LYMPHOMA; REGULATORY T LYMPHOCYTE; SHORT SURVEY; SURVIVAL TIME; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

EID: 79959350277     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1374     Document Type: Short Survey

References (14)

1. Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006 ; 6 : 836-48.
2. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006 ; 313 : 1960-4.
3. Pagès F, Galon J, Dieu-Nosjean MC, Tartour E, Sautès- Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010 ; 29 : 1093-102.
4. Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008 ; 26 : 4410-7.
5. Tesar BM, Chalasani G, Smith-Diggs L, Baddoura FK, Lakkis FG, Goldstein DR. Direct antigen presentation by a xenograft induces immunity independently of secondary lymphoid organs. J Immunol 2004 ; 173 : 4377-86.
6. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004 ; 10 : 927-34.
7. Gajewska BU, Alvarez D, Vidric M, et al. Generation of experimental allergic airways inflammation in the absence of draining lymph nodes. J Clin Invest 2001 ; 108 : 577-83.
8. Gill MK, Jampol LM. Variations in the presentation of primary intraocular lymphoma: case reports and a review. Surv Ophthalmol 2001 ; 45 : 463-71.
9. Chan CC, Fisson S, Bodaghi B. The future of primary intraocular lymphoma. Ocul Immunol Inflamm 2009 ; 17 : 375-9.
10. Touitou V, Daussy C, Bodaghi B, Camélo S, De Kozak Y, LeHoang P, et al. Impaired Th1/Tc1 cytokine production of tumor infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma. Invest Ophthalmol Vis Sci 2007 ; 48 : 3223-9.
11. Merle-Beral H, Davi F, Cassoux N, et al. Biological diagnosis of primary intraocular lymphoma. Br J Haematol 2004 ; 124 : 469-73.
12. Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm 2000 ; 8 : 243-50.
13. Fridman WH, Galon J, Dieu-Nosjean MC, et al. Immune infiltration in human cancer: prognostic significance and disease control. Curr Top Microbiol Immunol 2010 (in press).
14. Touitou V, Bodaghi B, De Kozak Y, LeHoang P, Sautès-Fridman C, Fisson S. Animal models of primary intraocular lymphomas and their applications in basic research and preclinical trials. Ophthalmic Res 2008 ; 40 : 208-11.